On Saturday, October 15, 2016, MassGeneral Hospital for Children (MGHfC) celebrated its seventeenth year of supporting pediatric health via Storybook Ball and raised close to $1.7 million. Demi & Tate Isenstadt, Tiffany & David Ortiz and Paige & Rick Sutphin co-chaired the event, which showcased the incredible strides MGHfC physicians and researchers are making in the field of medical genetics. When 500 black-tie guests arrived at The Castle (130 Columbus Avenue, Boston), they were welcomed into the whimsical world of Winnie-the-Pooh, as longtime Storybook Ball partner, Rafanelli Events, reinterpreted the A. A. Milne classic (90 years old this month) into a grand scale. Co-Chairs Demi Isenstadt, Tiffany Ortiz and Paige Sutphin kicked off the speaking program, which also featured Thomas J. Lynch Jr., MD, Chairman and CEO, Mass General Physicians Organization, Ronald E. Kleinman, MD, Physician-in-Chief, MGHfC, and Allan M. Goldstein, MD, Surgeon-in-Chief, MGHfC. A poignant patient story was shared, introducing guests to 10-year-old John Peters (JP) and his family, who have been traveling to Boston from Haymarket, Virginia, for five years working with a team of MGHfC doctors led by Dr. Ron Thibert, Director of the Dup15q Clinic at MGHfC. The evening included dinner by Max Ultimate Food, a live auction emceed by Lenny Clarke featuring one-of-a-kind packages like a Fender custom guitar autographed by Big Papi, dancing led by DJ Chris Roxx, and games, where winners took home prizes from luxury brands Giorgio Armani Beauty, Blank Label, bloomingdale’s, Broadway Restaurant Group, Daniela Corte, Gretta Luxe & Grettacole, North River Outfitter, PUMA, REMY, Rue La, Rita Sorrentino Makeup and Trinchero Family Estates. Since 2000, the Storybook Ball has raised more than $25 million for research initiatives and patient care programs at MGHfC. Proceeds from Storybook Ball over the past decade have allowed MGHfC to provide extraordinary care to the youngest patients and their families; to recruit and support the best physicians, surgeons and researchers; and to speed the development of new technologies and cutting-edge research that can transform clinical approaches locally and globally.